A detailed history of Hap Trading, LLC transactions in Amgen Inc stock. As of the latest transaction made, Hap Trading, LLC holds 10,000 shares of AMGN stock, worth $2.78 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,000
Previous 14,100 29.08%
Holding current value
$2.78 Million
Previous $64.5 Million 151.08%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $3.95 Million - $5.02 Million
17,251 Added 145.0%
29,148 $7.66 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $1.36 Million - $1.53 Million
-6,052 Reduced 33.72%
11,897 $2.68 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $535,016 - $595,380
-2,319 Reduced 11.44%
17,949 $4.37 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $1.24 Million - $1.37 Million
5,662 Added 38.76%
20,268 $4.9 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $2.9 Million - $3.32 Million
14,606 New
14,606 $3.29 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.